Literature DB >> 7227302

Dopamine in hypophysial portal plasma and prolactin in systemic plasma of rats treated with 5-hydroxytryptamine.

N S Pilotte, J C Porter.   

Abstract

Intracerebroventricularly administered 5-hydroxytryptamine (5HT) altered the release of dopamine into pituitary stalk blood and of PRL into the systemic circulation of male rats. The concentration of dopamine in pituitary stalk plasma of rats given 0.5 or 5.0 microgram 5HT was 0.32 +/- 0.06 (mean +/- SE) or 0.18 +/- 0.04 ng/ml, respectively, and was significantly less than that in vehicle-treated animals (0.80 +/- 0.04 ng/ml). Relative to the mean level of PRL in animals injected with the solvent vehicle, the mean concentration of PRL in central venous plasma of rats given 0.5 or 5.0 microgram 5HT was increased 4-fold or 13-fold, respectively. Other rats were infused iv with dopamine for 45 min. After 15 min of infusion, the mean concentration of dopamine in arterial plasma was several times that of dopamine in pituitary stalk plasma of rats not infused with dopamine. Even so, this high concentration of dopamine did not prevent the 5HT-induced release of PRL. We conclude that 5HT modulates the secretion of PRL through a stimulatory mechanism that is effective in the presence of a high plasma concentration of dopamine, a PRL-release inhibiting factor, and suggest that 5HT causes the release of a hypothalamic substance(s) that stimulates release of PRL, i.e. a PRL-releasing factor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7227302     DOI: 10.1210/endo-108-6-2137

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Ontogenic studies of the neural control of adenohypophyseal hormones in the rat. II. Prolactin.

Authors:  D Becú-Villalobos; I M Lacau-Mengido; G S Díaz-Torga; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1992-02       Impact factor: 5.046

2.  Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo.

Authors:  F Serres; Q Li; F Garcia; D K Raap; G Battaglia; N A Muma; L D Van de Kar
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

3.  Developing brain as an endocrine organ: a paradoxical reality.

Authors:  M V Ugrumov
Journal:  Neurochem Res       Date:  2010-02-05       Impact factor: 3.996

4.  Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.

Authors:  M Strolin Benedetti; A Eschalier; A Lesage; G Dordain; V Rovei; E Zarifian; P Dostert
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Inhibition by naloxone of the serotonin-induced prolactin release in free-moving rats.

Authors:  G M Somoza; G A Larrea; D Becú; D P Cardinali; C Libertun
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

6.  Responsiveness of tuberoinfundibular dopaminergic neurons to 5-hydroxytryptophan: effects of aging.

Authors:  P S MohanKumar; S M MohanKumar; S K Quadri; J L Voogt
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.